Pilot Awards
MRA Pilot Awards test potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.
To learn more about MRA funded research awards, please visit CureMelanoma.org/Grants
Overcoming Immunotherapy Resistance by Selective Inhibition of Notch1
MRA Pilot Award
Barbara Bedogni PhD, University of Miami, Miller School of Medicine
Imaging Biomarkers for Immunotherapy Resistance in Melanoma In Vivo
MRA Pilot Award
Pratip Bhattacharya PhD, University of Texas MD Anderson Cancer Center
Harnessing Proteasome Heterogeneity for Sensitization to Immunotherapy
MRA Pilot Award
Yifat Merbl PhD, Weizmann Institute of Science
Defining Mediators of Metastatic Spread in Acral Melanoma
MRA Pilot Award
Carla Daniela Robles-Espinoza PhD, Universidad Nacional
Autónoma de México
Dissecting the Impact of Noncoding Structural Variation in Melanoma Genomes
Leveraged Finance Fights Melanoma-MRA Pilot Award
Eliezer Van Allen MD, Dana-Farber Cancer Institute
Identifying and Targeting Melanoma Resident Macrophages
MRA Pilot Award